Variant report
Variant | nsv467223 |
---|---|
Chromosome Location | chr10:56245351-56262826 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:17)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:17 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr10:56255412-56255696 | A549 | lung: | n/a | chr10:56255576-56255587 |
2 | CEBPB | chr10:56255402-56255747 | HepG2 | liver: | n/a | chr10:56255576-56255587 |
3 | CTCF | chr10:56245983-56245998 | Spleen_OC | spleen: | n/a | n/a |
4 | EP300 | chr10:56251301-56251319 | Hela-S3 | cervix: | n/a | n/a |
5 | GATA3 | chr10:56251982-56252054 | SH-SY5Y | brain: | n/a | n/a |
6 | GATA3 | chr10:56261680-56262139 | MCF-7 | breast: | n/a | n/a |
7 | JUN | chr10:56254353-56254502 | K562 | blood: | n/a | n/a |
8 | MAFK | chr10:56247544-56247782 | HepG2 | liver: | n/a | chr10:56247675-56247686 chr10:56247674-56247689 chr10:56247675-56247686 |
9 | MAFK | chr10:56247535-56247784 | Hela-S3 | cervix: | n/a | chr10:56247675-56247686 chr10:56247674-56247689 chr10:56247675-56247686 |
10 | MAFK | chr10:56247569-56247774 | K562 | blood: | n/a | chr10:56247675-56247686 chr10:56247674-56247689 chr10:56247675-56247686 |
11 | MAFK | chr10:56247516-56247828 | HepG2 | liver: | n/a | chr10:56247675-56247686 chr10:56247674-56247689 chr10:56247675-56247686 |
12 | MAFK | chr10:56247545-56247825 | IMR90 | lung: | n/a | chr10:56247675-56247686 chr10:56247674-56247689 chr10:56247675-56247686 |
13 | MYC | chr10:56250759-56250801 | K562 | blood: | n/a | n/a |
14 | POLR2A | chr10:56252783-56252839 | GM12878 | blood: | n/a | n/a |
15 | POLR2A | chr10:56256869-56256894 | A549 | lung: | n/a | n/a |
16 | SPI1 | chr10:56258568-56258869 | HL-60 | blood: | n/a | n/a |
17 | ZNF143 | chr10:56246572-56246893 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MTRNR2L5-4 | chr10:56245990-56246076 | NONHSAT013457 |
2 | lnc-MTRNR2L5-4 | chr10:56245990-56246076 | ENSG00000234173.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000234173 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs16906192 | chr10:56245351-56245352 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs377668852 | chr10:56245368-56245369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577642936 | chr10:56245388-56245389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529970408 | chr10:56245833-56245834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536526123 | chr10:56245857-56245858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546493408 | chr10:56246010-56246011 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs558587897 | chr10:56246055-56246056 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs539948353 | chr10:56256626-56256627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142619354 | chr10:56256642-56256643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576066977 | chr10:56256646-56256647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535414695 | chr10:56256647-56256648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs370957486 | chr10:56256654-56256655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182799968 | chr10:56256656-56256657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143878285 | chr10:56256672-56256673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12782404 | chr10:56256682-56256683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs12784628 | chr10:56256687-56256688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12784650 | chr10:56256725-56256726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541244227 | chr10:56256727-56256728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187443537 | chr10:56256734-56256735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs578095915 | chr10:56256770-56256771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543551323 | chr10:56256773-56256774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs369501884 | chr10:56256777-56256778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs528906315 | chr10:56256834-56256835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192734715 | chr10:56256869-56256870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs559699824 | chr10:56256902-56256903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs66665873 | chr10:56256977-56256978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs147512407 | chr10:56262012-56262013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192452709 | chr10:56262092-56262093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553853489 | chr10:56262093-56262094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140073000 | chr10:56262140-56262141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1930143 | chr10:56262173-56262174 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs554857553 | chr10:56262179-56262180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs180831668 | chr10:56262245-56262246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12255357 | chr10:56262246-56262247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542100264 | chr10:56262269-56262270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs76416024 | chr10:56262275-56262276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs572542496 | chr10:56262277-56262278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11004341 | chr10:56262280-56262281 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs540445505 | chr10:56262296-56262297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs370193908 | chr10:56262310-56262311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs142999811 | chr10:56262374-56262375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150686616 | chr10:56262392-56262393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Melanoma | 17363583 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56244200-56245400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr10:56245800-56246000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr10:56256600-56257000 | Enhancers | Spleen | Spleen |
4 | chr10:56262000-56262400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |